Journo Jobs

BioPharm Insight seeks investigative health care reporter

February 7, 2014

Posted by Chris Roush

We are looking for a driven and diligent individual to join BioPharm Insight’s New York team as an investigative health care reporter covering cancer. The individual will cover all aspects of cancer drug development, approval and marketing and provide forward-looking intelligence through thorough reporting.

The individual will also cover business development, litigation and general trends within the cancer sector.

THE ROLE

Write informative articles on cancer drug development by gathering key intel months in advance of upcoming company catalysts.

Cover key elements of a drug’s life cycle including clinical trials, regulatory decisions, reimbursement and commercialization as well as collaborations, M&A and litigation.

Conduct interviews with all types of experts including high-level physicians, investigators/researchers, consultants, regulatory officials and industry executives.

Uncover new industry trends and facts.

Break news with timely, critical scoops on the pharma and biotech sector.

Attend health care and investor conferences.

PROFESSIONAL AND PERSONAL ATTRIBUTES

– Knowledge of the drug development process and healthcare industry required

– Excellent reporting, interviewing and writing skills required

– Ability to perform to a high standard under strict deadline pressure required

– Ability to work in an interactive news room environment required

– Two years of reporting experience covering cancer or other medical beats preferred

– Previous experience on a daily or weekly publication preferred

– Outstanding networking and contact building skills required

– Bachelor’s degree (preferably in Journalism and/or medical field) required

Interested candidates should send a cover letter, resume and two published writing samples to Querida Anderson, North American Editor, at qanderson@biopharminsight.com

Subscribe to TBN

Receive updates about new stories in the industry daily or weekly.

Subscribe to TBN

Receive updates about new stories in the industry.